Our mission

Traditional drug screening assays average signals from trillions of target molecules. Such averaging conceals the pharmacological properties of multiple, distinct, molecular states. Atomos is leveraging State-Content Analysis to circumvent averaging. With State-Content Analysis we directly characterise the individual native pharmacological states and unmask their selective regulation by drugs. This information enables the rational discovery, selection, and optimisation of lead compounds based on novel, accurate metrics of intrinsic drug efficacy.

Atomοs (from greek ἄτομος | ˈa.to.mos) means indivisible, it is the root of the word atom and here refers to the molecular states that underpin biological phenotypes.